Pitarotin 2 mg (Pitavastatin Calcium)

Adult dose

For adults, the usual starting dose is 1 to 2 mg of Pitavastatin Calcium once daily. If the LDL-cholesterol lowering effect is insufficient, the dose can be increased to a maximum of 4 mg daily. The dosage should be appropriately adjusted at intervals of 4 weeks or longer.

This medication should not be used in certain patients. For example, patients with allergies to the ingredients of this drug or with liver dysfunction, severe liver disease or bile duct obstruction, those taking cyclosporine, those with myopathy, women who are pregnant or may become pregnant, nursing mothers, and children should not receive this medication. In addition, patients with impaired kidney function or a history of liver disease, those who consume alcohol excessively, patients with hypothyroidism, elderly patients, and those with muscle weakness should use this medication with caution. While taking this medication, various side effects such as muscle pain, weakness, liver dysfunction, thrombocytopenia, and allergic reactions may occur, and if symptoms appear, consultation with a physician should be sought immediately. In particular, serious muscle disease known as rhabdomyolysis may occur rarely, hence if muscle pain or weakness is experienced, administration should be suspended immediately. Regular liver function tests are required, and if liver enzyme levels rise, treatment should be discontinued and appropriate measures taken. This medication may interact with other drugs, especially if taken with cyclosporine or fibrates, niacin, or erythromycin, as this may increase the risk of renal function deterioration and muscle damage, therefore co-administration should be avoided or used with caution. Elderly patients may experience side effects more readily when taking this medication, thus dosage adjustment and caution are necessary. Pregnant or nursing women should not take this medication, and if pregnancy is confirmed, administration should be discontinued immediately. Finally, the safety and efficacy of this medication have not been established in children, hence it should not be used in pediatric patients. Lastly, this medication should be kept out of the reach of children and stored in its original container to prevent misuse or deterioration in quality.

Serious side effects

• Urticaria
• angioedema
• rhabdomyolysis
• myopathy
• liver dysfunction
• jaundice
• thrombocytopenia
• acute renal failure
• severe allergic reactions
• serious skin adverse reactions

Mild side effects

• Abdominal pain
• rash
• fatigue
• itching
• stiffness
• drowsiness
• insomnia
• headache
• heaviness
• numbness

This medication should be stored in a container that blocks light and air, at room temperature between 1 to 30 degrees Celsius. Proper storage helps to maintain the effectiveness of the medication.

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle